Regeneron Pharmaceuticals Inc (REGN)

613.61
-1.35(-0.22%)
After Hours
612.51
-1.10(-0.18%)
- Real-time Data
  • Volume:
    566,479
  • Day's Range:
    606.96 - 621.63
  • 52 wk Range:
    538.01 - 747.42

REGN Overview

Prev. Close
614.96
Day's Range
606.96-621.63
Revenue
14.23B
Open
613.47
52 wk Range
538.01-747.42
EPS
53.27
Volume
566,479
Market Cap
65.6B
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
669,118
P/E Ratio
-
Beta
0.284
1-Year Change
0.45%
Shares Outstanding
106,908,322
Next Earnings Date
07 Nov 2022
What is your sentiment on Regeneron Pharma?
or
Market is currently closed. Voting is open during market hours.

Regeneron Pharmaceuticals Inc Analysis

Regeneron Pharmaceuticals Inc Company Profile

Regeneron Pharmaceuticals Inc Company Profile

Employees
9766

Regeneron Pharmaceuticals, Inc. is an integrated biotechnology company that discovers, invents, develops, manufactures, and commercializes medicines for serious diseases. Its commercialized medicines and product candidates in development are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, pain, hematologic conditions, infectious diseases, and rare diseases. Its marketed products include EYLEA (aflibercept) Injection, Dupixent (dupilumab) Injection, Libtayo (cemiplimab) Injection, Praluent (alirocumab) Injection, REGEN-COV, Kevzara (sarilumab) Solution for Subcutaneous Injection, Evkeeza (evinacumab) Injection, Inmazeb (atoltivimab, maftivimab, and odesivimab-ebgn) Injection, ARCALYST (rilonacept) Injection for Subcutaneous Use and ZALTRAP (ziv-aflibercept) Injection for Intravenous Infusion. It also provides Expresse service assurance and CloudCheck WiFi experience management solutions.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesBuyStrong BuyBuyBuyBuy
Technical IndicatorsStrong BuySellNeutralStrong BuyBuy
SummaryStrong BuyNeutralNeutralStrong BuyBuy